We follow industry news and trends so you can stay ahead of the game. Subscribe to receive emails regarding policies and findings that impact you and your business.

Already a subscriber and want to update your preferences? Click here.

BACK TO NEWS

MEDIA MENTIONS

JUL 11 2024

FDA Drug Approvals, Rulemaking Tested After Chevron Decision - Bloomberg Law

William Garvin, shareholder and co-chair of the firm's FDA section, was quoted in Bloomberg Law article "FDA Drug Approvals, Rulemaking Tested After Chevron Decision."